MORE►
biotech
OncoNano's technology visualizes a tongue carcinoma in real time during a surgery in a Phase 1 clinical trial. [Image: OncoNano]
Southlake BioTech Startup Gets $10M Grant from CPRIT for Technology That ‘Lights Up’ Cancer
by Quincy Preston | Aug 20, 2020
OncoNano Medicine, a spinout of University of Texas Southwestern, uses pH as a biomarker to detect metastatic cancer. Its technology, which visualizes a tumor, could be a gamechanger.
by Alex Edwards |
Jul 13, 2020
The mixed-use social purpose project—designed to boost local biotech, nonprofit, and corporate innovation—has been in the works for years. Expected to open in early 2021, the future-focused campus is located near the Dallas Medical District.
MORE►
by Alex Edwards |
Jul 13, 2020
CAGE Bio—currently a resident at Johnson & Johnson Innovation—uses a proprietary platform to develop therapeutic products for dermatology, inflammation, and immunology.
MORE►
by David Kirkpatrick |
Mar 13, 2020
Exact Diagnostics, which develops and manufactures products to ensure test result validity, will now help more laboratories keep pace with the increasing demand for COVID-19 testing.
MORE►
[Image: via iStock/lisblu]
The (Alcon) Family Tree: How One Company Seeded a DFW Life Science Legacy
by Jeff Bounds | Jan 21, 2020
Alcon gave rise to a startup ecosystem in North Texas that is spreading into all parts of how drugs, medical devices, and more are created.
MORE►
by David Kirkpatrick |
Dec 12, 2019
Panda Biotech's hemp facility is expected to process more than 130,000 tons of Texas-grown industrial hemp annually.
MORE►
by Lance Murray |
Sep 9, 2019
Among the contributions of recipient Paul Dorman, the chairman and CEO of DFB Pharmaceuticals, is paying for the first-year tuition of the entire inaugural class of M.D. students at the TCU and UNTHSC School of Medicine in Fort Worth.
MORE►
by Lance Murray |
Aug 27, 2019
Southlake-based biotech OncoNano received the largest grant in DFW with $15.4 million from the state agency that funds cancer research in Texas.
MORE►
Spectral MD's DeepView system looks beneath the skin's surface. [Photo: Spectral MD video]
Spectral MD Gets $27M to Advance Trials of AI-Powered Wound, Burn Care Device
by Lance Murray | Jul 24, 2019
Spectral's device uses real-time data and artificial intelligence to help look beneath the skin's surface and assess wound and burn damage, which can help doctors improve treatments and outcomes — as well as be a tool in the response to mass burn casualties in a national emergency.
MORE►
by Natalie Le |
May 28, 2019
The women-owned technology company—dubbed the "eharmony of the pharmaceutical industry"—is making it easier for life science professionals to connect with leading industry players such as AstraZeneca, Roche, Genentech in minutes.
MORE►
by Lance Murray |
May 22, 2019
The clinical-stage oncology company develops small molecule drugs to treat kidney cancer and other diseases. Its renal cell carcinoma drug is in a Phase II clinical trial.
MORE►
by Alex Edwards |
Apr 1, 2019
CerSci's focus is on alleviating human suffering and rescuing society from the ongoing opioid crisis via a pain drug that does not affect the central nervous system.
MORE►
Photo: typhoonski/iStockPhoto
Dallas to Host Federal BioTech Conference
by Dave Moore | Apr 27, 2018
Local startups and researchers can learn how to get federal research-and-tech-driven grant funding and meet federal experts in this conference hosted by the Dallas Regional Chamber.
MORE►
by Nicholas Sakelaris |
Nov 14, 2017
The Fort Worth biotech startup developed a topical treatment that dissolves earwax, the first over-the-counter product of its kind.
MORE►
by Nicholas Sakelaris |
Oct 13, 2017
From the future of Cancer Prevention & Research Institute of Texas grants to patient records innovation, leaders discussed issues facing the industry.
MORE►
by D'Anzia Robertson |
Oct 13, 2017
BionorthTX's annual summit brought industry leaders together to discuss the future of health care and impact of new technology.
MORE►
